Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance
about
Hydroxycut(®) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literatureScience of weight loss supplements: compromised by conflicts of interest?Ulcerative colitis associated with the herbal weight loss supplement HydroxycutNew Dietary Supplements for Obesity: What We Currently Know.Safety assessment of a calcium-potassium salt of (-)-hydroxycitric acid.Herbal hepatotoxicity: a hidden epidemic.Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans.Review article: herbal and dietary supplement hepatotoxicity.Hydroxycut-induced Liver Toxicity.Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation.Reversible cerebral vasoconstriction syndrome in a patient taking citalopram and Hydroxycut: a case report.No evidence demonstrating hepatotoxicity associated with hydroxycitric acid.Heart Toxicity Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 4 of 5.A Review of Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.Asystole caused by Hydroxycut Hardcore: A case report and literature review.Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature.
P2860
Q24610812-572B6271-6325-4FC3-A11F-0B754880B885Q24630937-F5EFBA96-450E-4A88-9370-7920238C99C4Q28282718-00BD57C2-6EFE-47C9-B574-744124DF4001Q34521126-A4CE5032-3DF0-4244-943C-23B8E76188C1Q37800105-62298753-5F83-4601-8D88-4BF2A13977F7Q38000141-5A445C91-CD6B-4247-91B9-648B41622882Q38005203-EC786ECF-A713-4088-B6DE-5D0E3E313A59Q38057354-E9902722-12A4-4841-864B-4B303D41C16BQ38263408-AD5A1D3B-DE11-405B-A963-16EB0F6896D1Q39065201-0259D334-AE20-41BF-A99D-194D2A55EB13Q40464465-472F4B6B-C589-453D-90D6-FAD1016713EEQ43064050-606D1538-8258-43BF-8458-F40B59A06CF4Q46294083-94620B96-B980-43AD-84DF-C0C30D7B4BB6Q47420209-25D05653-7F35-48AD-8F8E-927C7F479730Q48219129-15AB317F-C40E-4E87-AD38-0AB40F4F5B3AQ55413223-C9F776BA-41D9-4B40-A459-7739D651607D
P2860
Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatoxicity associated with w ...... er post-marketing surveillance
@ast
Hepatoxicity associated with w ...... er post-marketing surveillance
@en
Hepatoxicity associated with w ...... er post-marketing surveillance
@nl
type
label
Hepatoxicity associated with w ...... er post-marketing surveillance
@ast
Hepatoxicity associated with w ...... er post-marketing surveillance
@en
Hepatoxicity associated with w ...... er post-marketing surveillance
@nl
prefLabel
Hepatoxicity associated with w ...... er post-marketing surveillance
@ast
Hepatoxicity associated with w ...... er post-marketing surveillance
@en
Hepatoxicity associated with w ...... er post-marketing surveillance
@nl
P2860
P356
P1476
Hepatoxicity associated with w ...... er post-marketing surveillance
@en
P2093
P2860
P304
P356
10.3748/WJG.15.1786
P407
P577
2009-04-14T00:00:00Z